↓ Skip to main content

Methyldopa blocks MHC class II binding to disease-specific antigens in autoimmune diabetes

Overview of attention for article published in Journal of Clinical Investigation, April 2018
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (99th percentile)
  • High Attention Score compared to outputs of the same age and source (96th percentile)

Citations

dimensions_citation
42 Dimensions

Readers on

mendeley
69 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Methyldopa blocks MHC class II binding to disease-specific antigens in autoimmune diabetes
Published in
Journal of Clinical Investigation, April 2018
DOI 10.1172/jci97739
Pubmed ID
Authors

David A Ostrov, Aimon Alkanani, Kristen A McDaniel, Stephanie Case, Erin E Baschal, Laura Pyle, Sam Ellis, Bernadette Pöllinger, Katherine J Seidl, Viral N Shah, Satish K Garg, Mark A Atkinson, Peter A Gottlieb, Aaron W Michels

X Demographics

X Demographics

The data shown below were collected from the profiles of 31 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 69 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 69 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 19 28%
Student > Master 9 13%
Student > Ph. D. Student 8 12%
Student > Bachelor 7 10%
Student > Doctoral Student 5 7%
Other 7 10%
Unknown 14 20%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 13 19%
Medicine and Dentistry 11 16%
Immunology and Microbiology 11 16%
Chemistry 5 7%
Agricultural and Biological Sciences 3 4%
Other 11 16%
Unknown 15 22%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 297. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 15 February 2024.
All research outputs
#118,568
of 25,653,515 outputs
Outputs from Journal of Clinical Investigation
#119
of 17,273 outputs
Outputs of similar age
#2,845
of 343,836 outputs
Outputs of similar age from Journal of Clinical Investigation
#4
of 128 outputs
Altmetric has tracked 25,653,515 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 99th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 17,273 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 16.8. This one has done particularly well, scoring higher than 99% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 343,836 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 99% of its contemporaries.
We're also able to compare this research output to 128 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 96% of its contemporaries.